Old Web
English
Sign In
Acemap
>
authorDetail
>
Harold N Fisher
Harold N Fisher
Medicine
Percutaneous coronary intervention
Internal medicine
Drotrecogin alfa
Pathology
3
Papers
1
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
USE AND OUTCOME OF DUAL ANTIPLATELET THERAPY FOR ACUTE CORONARY SYNDROME IN PATIENTS WITH CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT), A MULTICENTRE PROSPECTIVE COHORT STUDY
2021
Canadian Journal of Cardiology
C Graham
Mary Tan
Dp Chew
Chris P Gale
K. A. A. Fox
Akshay Bagai
M. Henderson
Ata ur Rehman Quraishi
Jean-Pierre Déry
Asim Cheema
Harold N Fisher
D. Brieger
Sohrab Lutchmedial
S. Lavi
Brian Y.L. Wong
Tomas Cieza
Shamir R. Mehta
S.G. Goodman
Andrew T. Yan
Show All
Source
Cite
Save
Citations (0)
Iconographies supplémentaires de l'article : Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT)
2016
Jean-Pierre Déry
Shamir R. Mehta
Harold N Fisher
X Zhang
Y.E. Zhu
R. C. Welsh
S. Lavi
Tomas Cieza
Mark A. Henderson
Sohrab Lutchmedial
Anthony Della Siega
Asim N. Cheema
Brian Y.L. Wong
A. Kokis
Payam Dehghani
Shaun Goodman
Show All
Source
Cite
Save
Citations (0)
Use of drotrecogin alfa (activated) in a severe acute respiratory syndrome patient with severe sepsis.
2008
Canadian Journal of Infectious Diseases & Medical Microbiology
Donna McRitchie
Warda Farooq
Harold N Fisher
Show All
Source
Cite
Save
Citations (1)
1